Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
about
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialRadiation Therapy after Radical Prostatectomy: Implications for CliniciansSaudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancerGaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeRole of Dose Intensification for Salvage Radiation Therapy after Radical ProstatectomyRationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?FROGG high-risk prostate cancer workshop: patterns of practice and literature review. Part II post-radical prostatectomyNomograms in oncology: more than meets the eyeManagement of patients with biochemical recurrence after local therapy for prostate cancerExternal beam radiotherapy for localized prostate cancerProstate cancer: ESMO Consensus Conference Guidelines 2012A Urologist's Personal View of Prostate CancerTarget Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular ImagingSalvage radiotherapy after radical prostatectomy: prediction of biochemical outcomesAdjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyAn Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate CancerPrognostic outlier genes for enhanced prostate cancer treatment.Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era.Adjuvant and salvage radiation therapy after prostatectomy: investigating beliefs and practices of radiation oncologists.Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial.Counseling patients about sexual health when considering post-prostatectomy radiation treatment.Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer.Shared responsibility for treatment-related morbidity for prostate cancerPredicting 15-year prostate cancer specific mortality after radical prostatectomy.Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerSalvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges.Identification of men with the highest risk of early disease recurrence after radical prostatectomyCritical review of prostate cancer predictive toolsAndrogen deprivation therapy for prostate cancer-review of indications in 2010Role of radical prostatectomy for high-risk prostate cancer.Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma.Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trialDoes PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group.Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.
P2860
Q24605205-12CFE21E-F8E7-43E4-B3ED-D9095E9E5792Q26744531-7A4F4363-B9D5-4E86-879F-65EC5842BDE5Q26747782-136BF383-61D5-41E1-B8CB-C30569FE891DQ26751574-6505ADD8-69F1-4782-B1F3-872BA5098A80Q26765872-42170BC5-B196-44DB-990C-4F921D476C53Q26774847-C7804921-C005-4DE5-8777-1B99C4607464Q26777128-1014DF57-D5ED-4BD7-97DC-D02BB55EDDE2Q26827690-951CE3F5-8E70-4D63-93EC-B0911263246EQ26830260-CD097510-74E0-4DFB-92A1-CC54F069900FQ26849220-E94B0F14-AB2F-4CBE-95B7-F4F19977F48BQ26853068-435161F2-8262-44C0-B19F-FA2E58B7355FQ27022847-8B15FA9E-507E-4489-9C70-F142703337B2Q28072919-C2E3EC31-F2F7-49D8-AC6B-BF5272A27539Q28074669-7A74C04E-53D7-4F9C-8160-8587DB116A60Q28541306-A186D077-CD2B-47F3-A18D-ACDD677E497DQ28541950-31BA7774-1A53-451C-BF7B-6E062D1297C2Q28543958-C843F46A-F3B6-4B81-8D28-D75ED92A003AQ28550860-5B300A04-01EB-4452-83C7-6886D70B57C8Q30244674-A7BB1004-56A7-4A58-9C2A-DF1A31BB83ABQ30276626-F416F184-7FC6-4CC5-B2FA-A2D59871D4B6Q30278648-020EE00B-5128-417E-AE02-837C01B39B9DQ30385364-69C98BD0-3C26-4E73-8BB7-55B0FEA4CE8BQ30586073-7B5BE218-5038-4741-9C5F-562CE227CDA2Q33710312-E6EDEDD7-8AD4-4126-983E-0EFCDF941748Q33754012-0CFB08C4-D9ED-47B1-B016-9927DE4FF3D1Q33754017-60F10934-A092-46F2-A292-362F6B4539C7Q33759725-5AA869F4-8697-4A19-9AAC-72B1D2F65D2DQ33761075-E04C33E2-7004-41A4-858F-08A1404565F5Q33766462-1AE0249D-A45D-4F31-86AC-51C03720866FQ33825388-276369C0-6147-48DD-9229-20A53212A9BBQ34104562-E43CB9CF-BE22-4636-8E10-3D2CBFF94202Q34111603-4AE034A2-2B3E-4C7F-8339-DB076EED8D27Q34139187-29186DD7-5ACC-4CA1-9DDB-B9572D94743CQ34174451-0DF79B5F-6F96-4093-9D8E-42D192E92B38Q34208260-3464BC49-035A-47CA-BD3F-5F3AE2712345Q34325482-2F8431B8-88C9-495C-BFE8-5200D6A1FDE7Q34437308-8DE5EF86-C66D-4DC6-9B67-C51E1A174A5CQ34462816-DF095A45-253F-4B16-8A94-56317419CF9DQ34637944-2EEB216A-D0A9-49FD-9F8D-F4F36E3C25ECQ34725046-CF98A665-0A58-4494-9CC2-B9CFB1D6ABFE
P2860
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting the outcome of salv ...... r after radical prostatectomy.
@en
Predicting the outcome of salv ...... r after radical prostatectomy.
@nl
type
label
Predicting the outcome of salv ...... r after radical prostatectomy.
@en
Predicting the outcome of salv ...... r after radical prostatectomy.
@nl
prefLabel
Predicting the outcome of salv ...... r after radical prostatectomy.
@en
Predicting the outcome of salv ...... r after radical prostatectomy.
@nl
P2093
P2860
P356
P1476
Predicting the outcome of salv ...... r after radical prostatectomy.
@en
P2093
Alan Pollack
Andrew J Stephenson
Charles N Catton
Claus G Roehrborn
Daniel W Lin
Deborah A Kuban
Eric A Klein
Howard M Sandler
Jeff M Michalski
Jeffrey D Forman
P2860
P304
P356
10.1200/JCO.2006.08.9607
P407
P577
2007-05-01T00:00:00Z